Your browser doesn't support javascript.
loading
Actitud del paciente adulto con dermatitis atópica frente a su patología y tratamiento. Estudio ACTIDA / Attitude of the adult patient with atopic dermatitis to the disease and its treatment: The ACTIDA Study
Betlloch, I; Izu, R; Lleonart, M; Ferrer, M; Ferrando, J.
Affiliation
  • Betlloch, I; Hospital General de Alicante. Alicante. España
  • Izu, R; Hospital de Basurto. Bilbao. España
  • Lleonart, M; Novartis Farmacéutica S.A. Barcelona. España
  • Ferrer, M; Adknoma Health Research S.L. Barcelona. España
  • Ferrando, J; Hospital Clínic de Barcelona. Barcelona. España
Actas dermo-sifiliogr. (Ed. impr.) ; 101(2): 143-150, mar. 2010. tab, ilus
Article in Spanish | IBECS | ID: ibc-78491
Responsible library: ES1.1
Localization: BNCS
RESUMEN
Introducción y

objetivos:

Conocer la actitud de los pacientes adultos frente a la dermatitis atópica (DA) y su tratamiento. Material y

métodos:

Estudio transversal, multicéntrico, realizado en pacientes con al menos 2 brotes en el último año.

Resultados:

Doscientos veintisiete dermatólogos reclutaron 1.441 pacientes analizables, mayoritariamente mujeres con 3,6 brotes al año de media. La mayoría de los pacientes (97,2%) indicó que solicitaba, al menos ocasionalmente, asesoramiento médico ante nuevos brotes. El 72,2% recurrió a la terapia combinada (TC) en el último brote, independientemente de su intensidad, siendo las combinaciones de 2 fármacos (TC2) las más utilizadas. Los dermatólogos indicaron mayoritariamente TC, siendo la TC2 más frecuente para formas leves y casi sin enfermedad, y la TC de más de 2 fármacos en brotes moderados a muy graves.

Conclusiones:

Los tratamientos empleados por los pacientes ante un brote de DA son similares a los indicados por los dermatólogos (AU)
ABSTRACT

Objective:

To determine the attitude of adult patients with atopic dermatitis (AD) to their disease and its treatment. Material and

methods:

A multicenter, cross-sectional study was performed in patients with at least 2 outbreaks of AD in the previous year.

Results:

Two hundred twenty-seven dermatologists recruited 1441 analyzable patients, the majority women, with a mean of 3.6 outbreaks per year. Most of the patients (97.2%) indicated that they always or sometimes requested medical evaluation of a new outbreak. In the most recent outbreak, 72.2% had used combined therapy, regardless of the severity of the episode; 2-drug combinations were the most common. The majority of dermatologists prescribed combined therapy, most commonly a 2-drug combination for mild or minimal disease, and 3 or more drugs for moderate to very severe outbreaks.

Conclusions:

Treatments used by patients for an outbreak of AD are similar to those prescribed by dermatologists in recent outbreak (AU)
Subject(s)
Search on Google
Collection: National databases / Spain Database: IBECS Main subject: Attitude to Health / Adrenal Cortex Hormones / Anti-Allergic Agents / Dermatitis, Atopic / Immunosuppressive Agents Type of study: Controlled clinical trial / Observational study / Prevalence study / Risk factors Aspects: Social determinants of health / Patient-preference Limits: Adult / Female / Humans Language: Spanish Journal: Actas dermo-sifiliogr. (Ed. impr.) Year: 2010 Document type: Article Institution/Affiliation country: Adknoma Health Research S.L/España / Hospital Clínic de Barcelona/España / Hospital General de Alicante/España / Hospital de Basurto/España / Novartis Farmacéutica S.A/España
Search on Google
Collection: National databases / Spain Database: IBECS Main subject: Attitude to Health / Adrenal Cortex Hormones / Anti-Allergic Agents / Dermatitis, Atopic / Immunosuppressive Agents Type of study: Controlled clinical trial / Observational study / Prevalence study / Risk factors Aspects: Social determinants of health / Patient-preference Limits: Adult / Female / Humans Language: Spanish Journal: Actas dermo-sifiliogr. (Ed. impr.) Year: 2010 Document type: Article Institution/Affiliation country: Adknoma Health Research S.L/España / Hospital Clínic de Barcelona/España / Hospital General de Alicante/España / Hospital de Basurto/España / Novartis Farmacéutica S.A/España
...